Envoy Medical Surpasses Three-Month Visit Milestone for All 56 Patients in Pivotal Clinical Trial

About this update from Envoy Medical, Inc.

White Bear Lake, Minnesota--(Newsfile Corp. - July 21, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has surpassed the three-month milestone for all 56 patients enrolled in the Company's pivotal clinical trial evaluating the investigational fully implanted Acclaim® cochlear implant. This marks another important clinical trial milestone as the Company continues to build momentum with the hearing industry. "Envoy Medical continues to demonstrate its ability to execute," said Brent Lucas, Chief Executive Officer of Envoy Medical. "Each milestone achieved brings us one big step closer to our next major goal – submission of our PMA application to the FDA. We are steadily advancing toward our ultimate objective of bringing fully implanted cochlear implants to market in the United States." The Company is continuing to collect safety and other study measures as part of its ongoing pivotal trial, with full data to be included as part of Envoy Medical's planned Premarket Approval ("PMA") submission to the U.S. Food and Drug Administration ("FDA"). The Company anticipates achieving its six-month visit milestone by late 2026 and its 12-month visit milestone for the entire study by April 2027. To be added to the Envoy Medical email distribution list, please email [email protected] with COCH in the subject line. About Envoy Medical, Inc. Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance, and ultimately quality of life. About the Fully Implanted Acclaim® Cochlear Implant We believe the fully implanted Acclaim Cochlear Implant ("Acclaim CI") is a first-of-its-kind hearing device. Envoy Medical's fully implanted technology includes a sensor designed to leverage the natural anatomy of the ear instead of a microphone to capture sound. The Acclaim CI is designed to address severe ...

View stock analysis, news, and events for Envoy Medical, Inc.